Logo image
Home Academic units
Sign in
Human beta3 adrenergic receptor agonists containing cyclic ureidobenzenesulfonamides
Journal article   Peer reviewed

Human beta3 adrenergic receptor agonists containing cyclic ureidobenzenesulfonamides

E R Parmee, E M Naylor, L Perkins, V J Colandrea, H O Ok, M R Candelore, M A Cascieri, L Deng, W P Feeney, M J Forrest, …
Bioorganic & medicinal chemistry letters, Vol.9(5), pp.749-754
03/08/1999
PMID: 10201841

Abstract

Administration, Oral Urea - pharmacokinetics Humans Adrenergic beta-Agonists - pharmacology Receptors, Adrenergic, beta-3 Adrenergic beta-Agonists - pharmacokinetics Macaca mulatta Structure-Activity Relationship Adrenergic beta-2 Receptor Agonists Sulfonamides - pharmacology Urea - chemical synthesis Sulfonamides - pharmacokinetics Heart Rate - drug effects Sulfonamides - chemical synthesis Animals Urea - analogs & derivatives Adrenergic beta-1 Receptor Agonists Dogs Adrenergic beta-Agonists - chemical synthesis Receptors, Adrenergic, beta - drug effects Receptors, Adrenergic, beta - metabolism Urea - pharmacology
Human beta3 adrenergic receptor agonists containing 5-membered ring ureas were shown to be potent partial agonists with excellent selectivity over beta1 and beta2 binding. L-760,087 (4a) and L-764,646 (5a) (beta3 EC50 = 18 and 14 nM, respectively) stimulate lipolysis in rhesus monkeys (ED50 = 0.2 and 0.1 mg/kg, respectively) with minimal effects on heart rate. Oral absorption in dogs is improved over other urea analogs.

Metrics

24 Record Views

Details